FINHUB Insights

DGX · Q3 FY25 · Jul 1 – Sep 30, 2025

Quest Diagnostics Q3 FY25: where the revenue came from and where it went

Quest Diagnostics Q3 FY25: revenue $2.8B (+13% year over year). Net profit $0.25B. Largest cohort Diagnostic information $2.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 21, 2025 10-Q
Sankey diagram of Quest Diagnostics's income statement for Q3 FY25: revenue of $2.82 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.82B +13% year over year
Gross profit$0.95B 34% margin
Operating profit$0.39B 14% margin
Net profit$0.25B 9% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 2.82 100% +13%
Diagnostic information 2.76 98% +14%
All other 0.06 2% +0%
Cost of revenue−1.8766%
Gross profit0.9534% margin+1pp
SG&A−0.5018%+0pp
Other−0.062%+0pp
Operating profit0.3914% margin+0pp
Tax−0.08
Interest & other costs−0.06
Net profit0.259%+0pp
Filing on EDGAR More quarters of DGX

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.